Viewing Study NCT06586606


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-01-19 @ 2:52 PM
Study NCT ID: NCT06586606
Status: COMPLETED
Last Update Posted: 2024-12-18
First Post: 2024-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Overview

Official Title: A Two-Period Study to Evaluate the Effects of Multiple Oral Doses of Itraconazole on the Single Dose PK of MK-1708 in Healthy Participants
Status: COMPLETED
Status Verified Date: 2024-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of the study is to see what happens to levels of MK-1708 a person's body over time. Researchers will compare what happens to MK-1708 in the body when it is given with or without a medicine called itraconazole.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
MK-1708-003 OTHER MSD View